Oct 18, 2024
Advocacy | Health Care and Social Services Congressmembers Urge DEA to Extend Current Flexibilities for Telemedicine Prescription of Controlled SubstancesOn October 15, a group of eighteen U.S. Congressmembers, led by Representative Doris Matsui (D-Sacramento) and Earl L. “Buddy” Carter (R-Georgia), urged the Drug Enforcement Administration (DEA) to extend flexibilities for telemedicine prescribing of controlled...


